Statement re completion of fundraise
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
2 February 2022
CYBA plc
Acquisition of Narf Industries PR LLC and Narf Industries LLC ("Narf")
And
Placings to raise gross proceeds of £6 million for Working Capital and Acquisition
The Company announces that it has completed its fundraise for both the working capital of the Enlarged Group, together with the cash portion in respect of the acquisition of Narf, for a combined total of £6 million (the "Placings"), at a deemed issue price of two pence per share ("Placing Price").
On 29 July 2021, the Company announced the signing of a conditional agreement to acquire the entire issued members interests in Narf Industries LLC and Narf Industries PR LLC ("Narf") (the "Acquisition") for a consideration of $25,600,000, to be satisfied through the issue of new ordinary shares in the Company ("Consideration Shares"). Now with the Placings completed, the only remaining conditions for the Transaction are the passing of various resolutions set out in a notice of meeting contained in the Prospectus ("Resolutions"), the Prospectus approval, and readmission of the Company and its shares to the Official list ("Readmission"). The Company is in the process of finalising the Prospectus, which it intends to publish as soon as possible following final approval from the FCA. The Acquisition of Narf constitutes a reverse takeover for the purposes of the Listing Rules and requires the publication of a prospectus, prepared in accordance with the Prospectus Regulation Rules ("Prospectus").
A further announcement on the timing of the Acquisition, publication of the Prospectus and issue of the notice of meeting will follow.
ENDS
About CYBA plc
CYBA plc ("CYBA") is a special purpose acquisition company ("SPAC") seeking suitable acquisition targets in the Cyber Security sector. CYBA intends to implement its strategy focussed on building a group capable of offering Cyber and Cybersecurity solutions in the US and beyond.
The Company intends to leverage the deep industry knowledge of its board and associates to undertake due diligence on the commercial attributes of a target entity's business.
For further information on the Company please visit www.cybaplc.com , with the Company's Prospectus to be found at www.cybaplc.com/investor-relations/corporate-documents or contact:
|
Robert Mitchell
|
CYBA |
Tel: +44 (0) 20 3468 2212 |
|
Peter Krens |
Tennyson Securities |
Tel: +44 (0)207 186 9030 |
Important Notice
The content of this announcement has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 (FSMA). This announcement has been issued by and is the sole responsibility of the Company. The information in this announcement is subject to change.
This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the Securities Act), and may not be offered or sold, directly or indirectly, in or into the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States. This announcement is not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, the Republic of South Africa, Japan or any jurisdiction where to do so might constitute a violation of local securities laws or regulations (a Prohibited Jurisdiction). This announcement and the information contained herein are not for release, publication or distribution, directly or indirectly, to persons in a Prohibited Jurisdiction unless permitted pursuant to an exemption under the relevant local law or regulation in any such jurisdiction.
Forward-looking statements
Certain statements in this announcement constitute ''forward-looking statements''. Forward-looking statements include statements concerning the plans, objectives, goals, strategies and future operations and performance of the Company and the assumptions underlying these forward-looking statements. The Company uses the words ''anticipates'', ''estimates'', ''expects'', ''believes'', ''intends'', ''plans'', ''may'', ''will'', ''should'', and any similar expressions to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause the Company's actual results, performances or achievements to be materially different from any future results, performances or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future. These forward-looking statements speak only as at the date of this announcement. The Company is not obliged, and does not intend, to update or to revise any forward-looking statements, whether as a result of new information, future events or otherwise except to the extent required by any applicable law or regulation. All subsequent written or oral forward-looking statements attributable to the Company, or persons acting on behalf of the Company, are expressly qualified in their entirety by the cautionary statements contained throughout this announcement. As a result of these risks, uncertainties and assumptions, a prospective investor should not place undue reliance on these forward-looking statements.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 7 hours ago Luceco
- 7 hours ago Helios Towers
- 7 hours ago Wise Class A
- 7 hours ago EDX Medical Group Plc
- 8 hours ago Naked Wines